GlycoNet Investigator is developing a gel-based drug delivery system with a massive potential.
Catégorie : Network News
2019: Top 10 Research Advances from GlycoNet Investigators
As the new year approaches, here is a look back at some of the most exciting advances from GlycoNet researchers in 2019.
A tug-of-war in your immune system
GlycoNet Investigators are looking into using carbohydrate-binding proteins to help battle fungal pathogens.
Unlocking the door to potential therapeutic treatments for serious complications from infections
GlycoNet scientists solved the structure of an enzyme that could help burn victims and prevent deaths from different kinds of infections.
How a protein in your brain could protect against Alzheimer’s disease
GlycoNet Investigator sets the stage for new therapeutic strategies for Alzheimer’s disease.
Potent antimicrobial found that shows promise in fighting staph infections
GlycoNet researchers discovered a molecule against Methicillin-resistant (MRSA) bacteria.
The secret life of bacterial phosphonate biosynthesis, revealed
GlycoNet scientists identified an enzyme possibly related to bacterial virulence and antibiotic resistance.
GlycoNet research team uses bacterial enzymes to boost the expression of human polysialyltransferase
The direct biochemical approach helps direct cells to specific sites for more efficient and targeted treatment.
Harnessing the power of glycomics to improve drugs
Glycoscience expert Warren Wakarchuk is a Professor and Associate Scientific Director of the Canadian Glycomics Network
Announcing the GlycoNet travel award winners for the Canadian Science Policy Conference
Four Network trainees will participate in the conference where they will be exposed to a wide spectrum of topics and pressing issues in science and innovation policy
French 
English